Micrograph of a glioblastoma, a type of brain tumour. Credit: Nephron.

The Government of Australia has announced new funding of $100m to advance brain cancer research as part of efforts to provide a better life to people suffering from the disease.

Formed as an alliance between the Federal Government, philanthropists, medical experts, patients and their families, the Australian Brain Cancer Mission is intended to double patient survival rates over the coming decade.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Initially, the government is awarding $50m through the Medical Research Future Fund (MRFF) and $10m from the Minderoo Foundation’s Eliminate Cancer Initiative.

Additionally, $20m is provided from Cure Brain Cancer Foundation, with plans to issue the remaining $20m in the near future.

The mission is set to leverage a research plan developed by the Australian and international brain cancer treatment and research experts in collaboration with patients and their advocates.

“With an aim to provide clinical trial participation opportunity for every patient in the country, the mission intends to invest in clinical trials and new network for discovery.”

With an aim to provide clinical trial participation opportunity for every patient in the country, the mission intends to invest in clinical trials and new network for discovery.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Furthermore, the Australian Brain Cancer Mission is planning for additional international partnerships, expansion of research platforms and technologies, and promotion of research talent.

An arm of the international adaptive trial platform, GBM AGILE, will be established in the country for adults with glioblastoma.

The government has further decided to fund clinical trial centres of Australian and New Zealand Children’s Haematology Oncology Group (ANZCHOG) and provide support for consolidation of the national ZERO Children’s Cancer initiative.

The mission will be administered by a Strategic Advisory Group comprising patients, clinicians, researchers, co-investors, industry representatives and Australian Medical Research Advisory Board members.